Publications by authors named "Eline Feitsma"

Claim this Profile
D
Development and Validation of a Prognostic Model for Persistent Hypoparathyroidism After Total or Completion Thyroidectomy.
Sam P J van Dijk, Carolien C H M Maas, Ali Alshangi, M H Elise van Driel, Eline A Feitsma

Clin Otolaryngol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardized and Quantitative ICG Perfusion Assessment: Feasibility and Reproducibility in a Multicentre Setting.
Eline Feitsma, Hugo Schouw, Tim Hoffman, Sam van Dijk, Wido Heeman

Life (Basel)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing reference curves for vital tissue perfusion using quantitative near-infrared fluorescence imaging with indocyanine green.
Floris P Tange, Roderick C Peul, Pim van den Hoven, Stefan Koning, Mo W Kruiswijk, Eline A Feitsma

Langenbecks Arch Surg· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine.
David G Alleva, Eline A Feitsma, Yester F Janssen, Hendrikus H Boersma, Thomas M Lancaster

NPJ Vaccines· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452.
Eline A Feitsma, Yester F Janssen, Hendrikus H Boersma, Yannick van Sleen, Debbie van Baarle

Vaccine· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity in Utilization of Optical Imaging Guided Surgery for Identifying or Preserving the Parathyroid Glands-A Meta-Narrative Review.
Eline A Feitsma, Hugo M Schouw, Milou E Noltes, Wido Heeman, Wendy Kelder

Life (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452.
Yester F Janssen, Eline A Feitsma, Hendrikus H Boersma, David G Alleva, Thomas M Lancaster

Vaccine· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis